Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 175 articles:
HTML format
Text format



Single Articles


    June 2017
  1. CRANE PK, Trittschuh E, Mukherjee S, Saykin AJ, et al
    Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.
    Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216.
    PubMed     Text format     Abstract available


  2. DRACHMAN DA, Smith TW, Alkamachi B, Kane K, et al
    Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219.
    PubMed     Text format     Abstract available


  3. CHOURAKI V, Preis SR, Yang Q, Beiser A, et al
    Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Alzheimers Dement. 2017 Jun 8. pii: S1552-5260(17)30200.
    PubMed     Text format     Abstract available


  4. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Text format     Abstract available


    May 2017
  5. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Text format     Abstract available


  6. WILLETTE AA, Webb JL, Lutz MW, Bendlin BB, et al
    Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Alzheimers Dement. 2017 May 10. pii: S1552-5260(17)30148.
    PubMed     Text format     Abstract available


  7. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Text format     Abstract available


  8. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Text format     Abstract available


    April 2017
  9. CARMONA-IRAGUI M, Balasa M, Benejam B, Alcolea D, et al
    Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2017 Apr 29. pii: S1552-5260(17)30146.
    PubMed     Text format     Abstract available


  10. CARRILLO MC, Fillit H, Ganguli M, Knopman D, et al
    Letter to the Editor re: Nexus of Cancer & Alzheimer's.
    Alzheimers Dement. 2017 Apr 19. pii: S1552-5260(17)30142.
    PubMed     Text format    


  11. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Text format     Abstract available


    March 2017
  12. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Text format     Abstract available


  13. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Text format     Abstract available


  14. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Text format     Abstract available


  15. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Text format     Abstract available


  16. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Text format     Abstract available


  17. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Text format     Abstract available


  18. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Text format     Abstract available


  19. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Text format     Abstract available


  20. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Text format     Abstract available


  21. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Text format     Abstract available


  22. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.
    PubMed     Text format    


  23. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Text format     Abstract available


    February 2017
  24. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Text format     Abstract available


  25. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Text format     Abstract available


  26. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Text format     Abstract available


  27. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Text format     Abstract available


  28. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed     Text format    


  29. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Text format     Abstract available


  30. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Text format     Abstract available


  31. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Text format     Abstract available


  32. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Text format     Abstract available


  33. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Text format     Abstract available


  34. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Text format     Abstract available


    January 2017
  35. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Text format     Abstract available


  36. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.
    PubMed     Text format    


  37. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Text format     Abstract available


  38. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Text format     Abstract available


  39. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Text format     Abstract available



  40. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Text format     Abstract available


    December 2016
  41. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Text format     Abstract available


  42. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Text format     Abstract available


  43. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Text format     Abstract available


  44. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Text format     Abstract available


    November 2016
  45. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Text format     Abstract available


  46. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Text format     Abstract available


  47. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Text format     Abstract available


  48. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.
    PubMed     Text format    


    October 2016
  49. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Text format     Abstract available


  50. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Text format     Abstract available


  51. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Text format     Abstract available


  52. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Text format     Abstract available


  53. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Text format     Abstract available


  54. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Text format     Abstract available


    September 2016
  55. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Text format     Abstract available


  56. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Text format     Abstract available


  57. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Text format     Abstract available


  58. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Text format     Abstract available


  59. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Text format     Abstract available


  60. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Text format     Abstract available


  61. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Text format     Abstract available


  62. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Text format     Abstract available


  63. LANCTOT KL, Boot BP, Bain LJ, Hendrix JA, et al
    Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease.
    Alzheimers Dement. 2016;12:1031-2.
    PubMed     Text format    


    August 2016
  64. BATEMAN RJ, Benzinger TL, Berry S, Clifford DB, et al
    The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
    Alzheimers Dement. 2016 Aug 29. pii: S1552-5260(16)30048.
    PubMed     Text format     Abstract available


  65. SARRO L, Tosakulwong N, Schwarz CG, Graff-Radford J, et al
    An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.
    Alzheimers Dement. 2016 Aug 10. pii: S1552-5260(16)32682.
    PubMed     Text format     Abstract available


  66. SONG W, Hooli B, Mullin K, Jin SC, et al
    Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.
    Alzheimers Dement. 2016 Aug 9. pii: S1552-5260(16)30203.
    PubMed     Text format     Abstract available


  67. THEOFILAS P, Ehrenberg AJ, Dunlop S, Alho AT, et al
    Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
    Alzheimers Dement. 2016 Aug 8. pii: S1552-5260(16)32679.
    PubMed     Text format     Abstract available


    July 2016
  68. TAYLOR AN, Kambeitz-Ilankovic L, Gesierich B, Simon-Vermot L, et al
    Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease.
    Alzheimers Dement. 2016 Jul 15. pii: S1552-5260(16)32660.
    PubMed     Text format     Abstract available


  69. GISPERT JD, Suarez-Calvet M, Monte GC, Tucholka A, et al
    Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.
    Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30026.
    PubMed     Text format     Abstract available


  70. COLEY N, Gallini A, Ousset PJ, Vellas B, et al
    Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial.
    Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30085.
    PubMed     Text format     Abstract available


    June 2016
  71. SNYDER PJ
    DADM: The first 2 years of the Alzheimer Association's open access journal to support the research and development of novel biomarkers and diagnostic approaches.
    Alzheimers Dement. 2016 Jun 28. pii: S1552-5260(16)30310.
    PubMed     Text format    


  72. SOBOL NA, Hoffmann K, Frederiksen KS, Vogel A, et al
    Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.
    Alzheimers Dement. 2016 Jun 23. pii: S1552-5260(15)30002.
    PubMed     Text format     Abstract available


  73. CACERES A, Vargas JE, Gonzalez JR
    APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects.
    Alzheimers Dement. 2016 Jun 20. pii: S1552-5260(16)30283.
    PubMed     Text format     Abstract available


  74. HERRING A, Munster Y, Akkaya T, Moghaddam S, et al
    Kallikrein-8 inhibition attenuates Alzheimer's pathology in mice.
    Alzheimers Dement. 2016 Jun 18. pii: S1552-5260(16)30280.
    PubMed     Text format     Abstract available


  75. SUN X, Dong C, Levin B, Crocco E, et al
    APOE epsilon4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.
    Alzheimers Dement. 2016 Jun 16. pii: S1552-5260(16)30278.
    PubMed     Text format     Abstract available


  76. SNYDER HM, Cardenas-Aguayo Mdel C, Alonso A, Bain L, et al
    Alzheimer's disease research in Ibero America.
    Alzheimers Dement. 2016;12:749-54.
    PubMed     Text format    


    May 2016
  77. GEERTS H, Dacks PA, Devanarayan V, Haas M, et al
    From big data to smart data in Alzheimer's disease. The brain health modeling initiative to foster actionable knowledge.
    Alzheimers Dement. 2016 May 26. pii: S1552-5260(16)30246.
    PubMed     Text format     Abstract available


  78. SHI M, Kovac A, Korff A, Cook TJ, et al
    CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease.
    Alzheimers Dement. 2016 May 24. pii: S1552-5260(16)30242.
    PubMed     Text format     Abstract available


  79. BERECZKI E, Francis PT, Howlett D, Pereira JB, et al
    Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.
    Alzheimers Dement. 2016 May 22. pii: S1552-5260(16)30244.
    PubMed     Text format     Abstract available


  80. CALSOLARO V, Edison P
    Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
    Alzheimers Dement. 2016 May 11. pii: S1552-5260(16)30185.
    PubMed     Text format     Abstract available


  81. ROSES A, Sundseth S, Saunders A, Gottschalk W, et al
    Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease.
    Alzheimers Dement. 2016 May 3. pii: S1552-5260(16)30118.
    PubMed     Text format     Abstract available


  82. PRIOR M, Goldberg J, Chiruta C, Farrokhi C, et al
    Selecting for neurogenic potential as an alternative for Alzheimer's drug discovery.
    Alzheimers Dement. 2016 May 2. pii: S1552-5260(16)30117.
    PubMed     Text format     Abstract available


  83. WENINGER S, Carrillo MC, Dunn B, Aisen PS, et al
    Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
    Alzheimers Dement. 2016;12:631-2.
    PubMed     Text format    


    April 2016
  84. TOSUN D, Chen YF, Yu P, Sundell KL, et al
    Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort.
    Alzheimers Dement. 2016 Apr 21. pii: S1552-5260(16)30192.
    PubMed     Text format     Abstract available


  85. GRAFF-RADFORD NR, Besser LM, Crook JE, Kukull WA, et al
    Neuropathologic differences by race from the National Alzheimer's Coordinating Center.
    Alzheimers Dement. 2016 Apr 16. pii: S1552-5260(16)30182.
    PubMed     Text format     Abstract available


  86. ALLEN GI, Amoroso N, Anghel C, Balagurusamy V, et al
    Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.
    Alzheimers Dement. 2016 Apr 11. pii: S1552-5260(16)00081.
    PubMed     Text format     Abstract available


  87. RABINOVICI GD, Karlawish J, Knopman D, Snyder HM, et al
    Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
    Alzheimers Dement. 2016;12:510-5.
    PubMed     Text format     Abstract available



  88. 2016 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2016;12:459-509.
    PubMed     Text format     Abstract available


  89. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Text format     Abstract available


  90. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Text format     Abstract available


    March 2016
  91. HENDRIX JA, Bateman RJ, Brashear HR, Duggan C, et al
    Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
    Alzheimers Dement. 2016 Mar 24. pii: S1552-5260(16)00082.
    PubMed     Text format     Abstract available


  92. CACACE R, Sleegers K, Van Broeckhoven C
    Molecular genetics of early-onset Alzheimer disease revisited.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00079.
    PubMed     Text format     Abstract available


  93. YU L, Chibnik L, Yang J, McCabe C, et al
    Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00084.
    PubMed     Text format     Abstract available


  94. GREEN C, Zhang S
    Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00078.
    PubMed     Text format     Abstract available


  95. SCHOTT JM, Crutch SJ, Carrasquillo MM, Uphill J, et al
    Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.
    Alzheimers Dement. 2016 Mar 15. pii: S1552-5260(16)00077.
    PubMed     Text format     Abstract available


  96. DI STEFANO F, Kas A, Habert MO, Decazes P, et al
    The phenotypical core of Alzheimer-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study.
    Alzheimers Dement. 2016 Mar 14. pii: S1552-5260(16)00075.
    PubMed     Text format     Abstract available


  97. MOLINUEVO JL, Cami J, Carne X, Carrillo MC, et al
    Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.
    Alzheimers Dement. 2016 Mar 14. pii: S1552-5260(16)00076.
    PubMed     Text format     Abstract available


  98. DUBOIS B, Hampel H, Feldman HH, Scheltens P, et al
    Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
    Alzheimers Dement. 2016;12:292-323.
    PubMed     Text format     Abstract available


  99. KHACHATURIAN ZS, Mesulam MM, Mohs RC, Khachaturian AS, et al
    Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?
    Alzheimers Dement. 2016;12:213-5.
    PubMed     Text format    


    February 2016
  100. RUIZ HH, Chi T, Lindtner C, Hsieh W, et al
    Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels.
    Alzheimers Dement. 2016 Feb 26. pii: S1552-5260(16)00049.
    PubMed     Text format     Abstract available


  101. LOUWERSHEIMER E, Wolfsgruber S, Espinosa A, Lacour A, et al
    Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment.
    Alzheimers Dement. 2016 Feb 24. pii: S1552-5260(16)00046.
    PubMed     Text format     Abstract available


  102. THOMAS RG, Albert M, Petersen RC, Aisen PS, et al
    Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials.
    Alzheimers Dement. 2016 Feb 22. pii: S1552-5260(16)00032.
    PubMed     Text format     Abstract available


  103. BROOKMEYER R, Kawas CH, Abdallah N, Paganini-Hill A, et al
    Impact of interventions to reduce Alzheimer disease pathology on the prevalence of dementia in the oldest-old.
    Alzheimers Dement. 2016 Feb 17. pii: S1552-5260(16)00034.
    PubMed     Text format     Abstract available


  104. SANDER K, Lashley T, Gami P, Gendron T, et al
    Characterization of tau positron emission tomography tracer [F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias.
    Alzheimers Dement. 2016 Feb 15. pii: S1552-5260(16)00033.
    PubMed     Text format     Abstract available


  105. BORSON S, Boustani MA, Buckwalter KC, Burgio LD, et al
    Report on milestones for care and support under the U.S. National Plan to Address Alzheimer's Disease.
    Alzheimers Dement. 2016 Feb 8. pii: S1552-5260(16)00035.
    PubMed     Text format     Abstract available


  106. BUCKLEY RF, Maruff P, Ames D, Bourgeat P, et al
    Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.
    Alzheimers Dement. 2016 Feb 4. pii: S1552-5260(16)00015.
    PubMed     Text format     Abstract available


  107. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Text format     Abstract available


  108. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Text format     Abstract available


    January 2016
  109. ABNER EL, Nelson PT, Kryscio RJ, Schmitt FA, et al
    Diabetes is associated with cerebrovascular but not Alzheimer neuropathology.
    Alzheimers Dement. 2016 Jan 23. pii: S1552-5260(15)03030.
    PubMed     Text format     Abstract available


  110. PODLESNIY P, Llorens F, Golanska E, Sikorska B, et al
    Mitochondrial DNA differentiates Alzheimer from Creutzfeldt-Jakob disease.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03035.
    PubMed     Text format     Abstract available


  111. KELLER A, Backes C, Haas J, Leidinger P, et al
    Validating Alzheimer's disease micro RNAs using next-generation sequencing.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03036.
    PubMed     Text format     Abstract available


  112. CLARK LR, Racine AM, Koscik RL, Okonkwo OC, et al
    Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03033.
    PubMed     Text format     Abstract available


  113. CASANOVA R, Varma S, Simpson B, Kim M, et al
    Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03032.
    PubMed     Text format     Abstract available


  114. DE WILDE MC, Overk CR, Sijben JW, Masliah E, et al
    Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.
    Alzheimers Dement. 2016 Jan 14. pii: S1552-5260(15)03029.
    PubMed     Text format     Abstract available


  115. HONDIUS DC, van Nierop P, Li KW, Hoozemans JJ, et al
    Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.
    Alzheimers Dement. 2016 Jan 6. pii: S1552-5260(15)02987.
    PubMed     Text format     Abstract available


  116. GAUTHIER S, Albert M, Fox N, Goedert M, et al
    Why has therapy development for dementia failed in the last two decades?
    Alzheimers Dement. 2016;12:60-4.
    PubMed     Text format     Abstract available


  117. PANNEE J, Gobom J, Shaw LM, Korecka M, et al
    Round robin test on quantification of amyloid-beta 1-42 in cerebrospinal fluid by mass spectrometry.
    Alzheimers Dement. 2016;12:55-9.
    PubMed     Text format     Abstract available


  118. GORDON MF, Lenderking WR, Duhig A, Chandler J, et al
    Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.
    Alzheimers Dement. 2016;12:75-84.
    PubMed     Text format     Abstract available


    December 2015
  119. LEVY NOGUEIRA M, Epelbaum S, Steyaert JM, Dubois B, et al
    Mechanical stress models of Alzheimer's disease pathology.
    Alzheimers Dement. 2015 Dec 21. pii: S1552-5260(15)02952.
    PubMed     Text format     Abstract available


  120. ROLLO JL, Banihashemi N, Vafaee F, Crawford JW, et al
    Unraveling the mechanistic complexity of Alzheimer's disease through systems biology.
    Alzheimers Dement. 2015 Dec 15. pii: S1552-5260(15)02985.
    PubMed     Text format     Abstract available


    November 2015
  121. ZHANG C, Kuo CC, Moghadam SH, Monte L, et al
    Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2015 Nov 7. pii: S1552-5260(15)02913.
    PubMed     Text format     Abstract available


  122. KHACHATURIAN ZS, Mesulam MM, Khachaturian AS, Mohs RC, et al
    The Special Topics Section of Alzheimer's & Dementia.
    Alzheimers Dement. 2015;11:1261-4.
    PubMed     Text format    


    October 2015
  123. ANDRIEU S, Coley N, Rolland Y, Cantet C, et al
    Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives.
    Alzheimers Dement. 2015 Oct 23. pii: S1552-5260(15)02904.
    PubMed     Text format     Abstract available


  124. EBBERT MT, Boehme KL, Wadsworth ME, Staley LA, et al
    Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
    Alzheimers Dement. 2015 Oct 5. pii: S1552-5260(15)02866.
    PubMed     Text format     Abstract available


    September 2015
  125. BARRAL S, Cheng R, Reitz C, Vardarajan B, et al
    Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2015 Sep 30. pii: S1552-5260(15)02650.
    PubMed     Text format     Abstract available


  126. KUNKLE BW, Jaworski J, Barral S, Vardarajan B, et al
    Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2015 Sep 10. pii: S1552-5260(15)00224.
    PubMed     Text format     Abstract available


  127. HUBIN E, Vanschoenwinkel B, Broersen K, De Deyn PP, et al
    Could ecosystem management provide a new framework for Alzheimer's disease?
    Alzheimers Dement. 2015 Sep 1. pii: S1552-5260(15)02668.
    PubMed     Text format     Abstract available


  128. LEHMANN S, Gabelle A, Paquet C
    Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?
    Alzheimers Dement. 2015;11:1125-6.
    PubMed     Text format    


    August 2015
  129. MONTINE TJ, Monsell SE, Beach TG, Bigio EH, et al
    Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Alzheimers Dement. 2015 Aug 29. pii: S1552-5260(15)02669.
    PubMed     Text format     Abstract available


  130. TOGA AW, Neu SC, Bhatt P, Crawford KL, et al
    The Global Alzheimer's Association Interactive Network.
    Alzheimers Dement. 2015 Aug 25. pii: S1552-5260(15)02651.
    PubMed     Text format     Abstract available


  131. HYMAN BT, Growdon JH, Albers MW, Buckner RL, et al
    Massachusetts Alzheimer's Disease Research Center: Progress and challenges.
    Alzheimers Dement. 2015 Aug 19. pii: S1552-5260(15)02124.
    PubMed     Text format    


    July 2015
  132. SIEMERS ER, Sundell KL, Carlson C, Case M, et al
    Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
    Alzheimers Dement. 2015 Jul 31. pii: S1552-5260(15)02148.
    PubMed     Text format     Abstract available


  133. RAMIREZ J, McNeely AA, Scott CJ, Masellis M, et al
    White matter hyperintensity burden in elderly cohort studies. The Sunnybrook Dementia Study, Alzheimer Disease Neuroimaging Initiative, and Three-City Study.
    Alzheimers Dement. 2015 Jul 21. pii: S1552-5260(15)02123.
    PubMed     Text format     Abstract available


  134. HUNTER CA, Kirson NY, Desai U, Cummings AK, et al
    Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries.
    Alzheimers Dement. 2015 Jul 20. pii: S1552-5260(15)02126.
    PubMed     Text format     Abstract available


  135. AGADJANYAN MG, Petrovsky N, Ghochikyan A
    A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease.
    Alzheimers Dement. 2015 Jul 17. pii: S1552-5260(15)02121.
    PubMed     Text format     Abstract available


  136. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
    Alzheimers Dement. 2015;11:865-84.
    PubMed     Text format     Abstract available


  137. JONES-DAVIS DM, Buckholtz N
    The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
    Alzheimers Dement. 2015;11:860-4.
    PubMed     Text format     Abstract available


  138. HENDRIX JA, Finger B, Weiner MW, Frisoni GB, et al
    The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
    Alzheimers Dement. 2015;11:850-9.
    PubMed     Text format     Abstract available


  139. LIU E, Luthman J, Cedarbaum JM, Schmidt ME, et al
    Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
    Alzheimers Dement. 2015;11:840-9.
    PubMed     Text format     Abstract available


  140. TOGA AW, Crawford KL
    The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review.
    Alzheimers Dement. 2015;11:832-9.
    PubMed     Text format     Abstract available


  141. BECKETT LA, Donohue MC, Wang C, Aisen P, et al
    The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.
    Alzheimers Dement. 2015;11:823-31.
    PubMed     Text format     Abstract available


  142. FRANKLIN EE, Perrin RJ, Vincent B, Baxter M, et al
    Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.
    Alzheimers Dement. 2015;11:815-22.
    PubMed     Text format     Abstract available


  143. KANG JH, Korecka M, Figurski MJ, Toledo JB, et al
    The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
    Alzheimers Dement. 2015;11:772-91.
    PubMed     Text format     Abstract available


  144. JAGUST WJ, Landau SM, Koeppe RA, Reiman EM, et al
    The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
    Alzheimers Dement. 2015;11:757-71.
    PubMed     Text format     Abstract available


  145. JACK CR JR, Barnes J, Bernstein MA, Borowski BJ, et al
    Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
    Alzheimers Dement. 2015;11:740-56.
    PubMed     Text format     Abstract available


  146. AISEN PS, Petersen RC, Donohue M, Weiner MW, et al
    Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans.
    Alzheimers Dement. 2015;11:734-9.
    PubMed     Text format     Abstract available


  147. WEINER MW, Veitch DP
    Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2015;11:730-3.
    PubMed     Text format     Abstract available


  148. THIES WH
    Alzheimer's Disease Neuroimaging Initiative: A decade of progress in Alzheimer's disease.
    Alzheimers Dement. 2015;11:727-9.
    PubMed     Text format    


    June 2015
  149. THAL DR, Beach TG, Zanette M, Heurling K, et al
    [F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-beta pathology.
    Alzheimers Dement. 2015 Jun 30. pii: S1552-5260(15)00216.
    PubMed     Text format     Abstract available


  150. LIU H, Qiu H, Yang J, Ni J, et al
    Chronic hypoxia facilitates Alzheimer's disease through demethylation of gamma-secretase by downregulating DNA methyltransferase 3b.
    Alzheimers Dement. 2015 Jun 26. pii: S1552-5260(15)00217.
    PubMed     Text format     Abstract available


  151. HOHMAN TJ, Cooke-Bailey JN, Reitz C, Jun G, et al
    Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.
    Alzheimers Dement. 2015 Jun 16. pii: S1552-5260(15)00190.
    PubMed     Text format     Abstract available


  152. DE VOS A, Jacobs D, Struyfs H, Fransen E, et al
    C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
    Alzheimers Dement. 2015 Jun 16. pii: S1552-5260(15)00181.
    PubMed     Text format     Abstract available


  153. LEVY NOGUEIRA M, Lafitte O, Steyaert JM, Bakardjian H, et al
    Mechanical stress related to brain atrophy in Alzheimer's disease.
    Alzheimers Dement. 2015 Jun 15. pii: S1552-5260(15)00196.
    PubMed     Text format     Abstract available


  154. SLEEGERS K, Bettens K, De Roeck A, Cauwenberghe CV, et al
    A 22-single nucleotide polymorphism Alzheimer risk score correlates with family history, onset age, and cerebrospinal fluid Abeta.
    Alzheimers Dement. 2015 Jun 15. pii: S1552-5260(15)00191.
    PubMed     Text format     Abstract available


  155. MUKHERJEE S, Walter S, Kauwe JS, Saykin AJ, et al
    Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00184.
    PubMed     Text format     Abstract available


  156. ROSEN C, Farahmand B, Skillback T, Nagga K, et al
    Benchmarking biomarker-based criteria for Alzheimer's disease-Data from the Swedish Dementia Registry, SveDem.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00185.
    PubMed     Text format     Abstract available


  157. NORDESTGAARD LT, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, et al
    Loss-of-function mutation in ABCA1 and risk of Alzheimer and cerebrovascular disease.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00180.
    PubMed     Text format     Abstract available


  158. LUTZ MW, Saul R, Linnertz C, Glenn OC, et al
    A CT-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00179.
    PubMed     Text format     Abstract available


  159. HANDELS RL, Joore MA, Tran-Duy A, Wimo A, et al
    Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment.
    Alzheimers Dement. 2015 Jun 9. pii: S1552-5260(15)00176.
    PubMed     Text format     Abstract available


  160. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Alzheimers Dement. 2015;11:e1-e120.
    PubMed     Text format     Abstract available


    May 2015
  161. RISACHER SL, Kim S, Nho K, Foroud T, et al
    APOE effect on Alzheimer's biomarkers in older adults with significant memory concern.
    Alzheimers Dement. 2015 May 7. pii: S1552-5260(15)00124.
    PubMed     Text format     Abstract available


  162. PASQUINI L, Scherr M, Tahmasian M, Meng C, et al
    Link between hippocampus' raised local and eased global intrinsic connectivity in AD.
    Alzheimers Dement. 2015;11:475-84.
    PubMed     Text format     Abstract available


    April 2015
  163. HUANG Y, Ito K, Billing CB Jr, Anziano RJ, et al
    Development of a straightforward and sensitive scale for MCI and early AD clinical trials.
    Alzheimers Dement. 2015;11:404-14.
    PubMed     Text format     Abstract available


    March 2015

  164. 2015 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2015;11:332-84.
    PubMed     Text format     Abstract available


    February 2015
  165. FRISONI GB, Jack CR
    HarP: the EADC-ADNI Harmonized Protocol for manual hippocampal segmentation. A standard of reference from a global working group.
    Alzheimers Dement. 2015;11:107-10.
    PubMed     Text format    


  166. APOSTOLOVA LG, Zarow C, Biado K, Hurtz S, et al
    Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.
    Alzheimers Dement. 2015;11:139-50.
    PubMed     Text format     Abstract available


  167. DUCHESNE S, Valdivia F, Robitaille N, Mouiha A, et al
    Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project.
    Alzheimers Dement. 2015;11:161-74.
    PubMed     Text format     Abstract available


  168. BOCCARDI M, Bocchetta M, Morency FC, Collins DL, et al
    Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Alzheimers Dement. 2015;11:175-83.
    PubMed     Text format     Abstract available


  169. FRISONI GB, Jack CR Jr, Bocchetta M, Bauer C, et al
    The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.
    Alzheimers Dement. 2015;11:111-25.
    PubMed     Text format     Abstract available


  170. BOCCHETTA M, Boccardi M, Ganzola R, Apostolova LG, et al
    Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project.
    Alzheimers Dement. 2015;11:151-60.
    PubMed     Text format     Abstract available


  171. BOCCHETTA M, Galluzzi S, Kehoe PG, Aguera E, et al
    The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
    Alzheimers Dement. 2015;11:195-206.
    PubMed     Text format     Abstract available


  172. BOCCARDI M, Bocchetta M, Apostolova LG, Barnes J, et al
    Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance.
    Alzheimers Dement. 2015;11:126-38.
    PubMed     Text format     Abstract available


  173. DAIELLO LA, Gongvatana A, Dunsiger S, Cohen RA, et al
    Association of fish oil supplement use with preservation of brain volume and cognitive function.
    Alzheimers Dement. 2015;11:226-35.
    PubMed     Text format     Abstract available


  174. BOCCARDI M, Bocchetta M, Ganzola R, Robitaille N, et al
    Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation.
    Alzheimers Dement. 2015;11:184-94.
    PubMed     Text format     Abstract available


    January 2015
  175. KLUNK WE, Koeppe RA, Price JC, Benzinger TL, et al
    The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
    Alzheimers Dement. 2015;11:1-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: